세계의 당뇨병 치료 시장 보고서(2025년)
Diabetes Care Global Market Report 2025
상품코드 : 1760520
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,471,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,354,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,236,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

당뇨병 치료 시장 규모는 향후 몇 년 동안 강력한 성장세를 보일 것으로 예상되며, 2029년까지 8.9%의 CAGR로 412억 1,000만 달러에 달할 것으로 예상됩니다. 예측 기간 동안 당뇨병 유병률 증가, 노인 인구 증가, 당뇨병 관리에 대한 인식 증가, 개발도상국의 의료 서비스 접근성 향상으로 인해 시장이 성장할 것으로 예상됩니다. 예측 기간 동안 예상되는 주요 동향으로는 당뇨병 모니터링 기술 발전, 당뇨병 치료에 인공지능(AI) 통합, 인슐린 전달 시스템 개선, 스마트 인슐린 기기 개발 등이 있습니다.

비만 유병률의 증가는 향후 몇 년 동안 당뇨병 치료 시장의 확대를 촉진할 것으로 예상됩니다. 비만율은 인구 중 체질량지수(BMI)가 30 이상인 사람의 비율을 의미합니다. 비만 증가는 좌식 생활에 대한 의존도 증가와 영양가가 낮은 가공된 고칼로리 식품의 소비가 확산되면서 칼로리 섭취와 운동량의 균형이 깨진 것이 주요 원인으로 작용하고 있습니다. 당뇨병 치료는 더 나은 생활습관을 장려하고, 혈당 조절을 강화하며, 인슐린 요법 및 연속 혈당 모니터링(CGM) 기술과 같은 첨단 치료 옵션을 통해 체중 조절을 지원함으로써 비만과 관련된 건강 문제를 해결하는 데 필수적입니다. 예를 들어, 2024년 3월, 스위스에 본부를 둔 정부 간 기구인 세계보건기구(WHO)는 2022년에 3억 9,000만 명의 성인이 저체중이고, 25억 명이 과체중이며, 그 중 8억 9,000만 명이 비만으로 분류될 것이라고 보고했습니다. 그 결과, 비만율의 증가는 당뇨병 치료 시장의 수요를 증가시키고 있습니다.

당뇨병 치료 업계의 주요 기업들은 자동 인슐린 전달(AID) 시스템과 같은 새로운 기술을 통해 지속적인 혈당 모니터링 기기와 인슐린 펌프를 원활하게 통합하고 실시간 인슐린 조절을 통해 혈당 조절을 강화하는 새로운 기술을 혁신하고 있습니다. 시스템은 CGM과 인슐린 펌프를 결합하여 현재 혈당을 기반으로 인슐린 수치를 자동으로 관리하여 환자가 보다 안정적인 혈당 조절을 유지할 수 있도록 도와줍니다. 예를 들어, 2024년 2월 미국의 당뇨병 치료 전문 의료기기 회사인 Tandem Diabetes Care Inc.는 초소형 내구성 자동 인슐린 전달 시스템인 Tandem Mobi를 출시하였습니다. 이 눈에 잘 띄지 않는 튜브형 인슐린 펌프는 스마트폰 앱으로 완전히 조작할 수 있어 기존의 컨트롤러가 필요 없습니다. 이 장치는 방수, 충전식이며 Dexcom의 CGM 시스템과 통합되어 Tandem이 확립한 Control-IQ 기술을 활용하여 인슐린 투여를 자동화합니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별·국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 주요 기업과 혁신적 기업

제32장 세계의 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병

제34장 최근의 시장 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

제36장 부록

ksm
영문 목차

영문목차

Diabetes care refers to the comprehensive management and treatment of diabetes mellitus, a chronic condition marked by elevated blood sugar levels. It includes a variety of medical, lifestyle, and technological interventions aimed at keeping blood glucose within a target range and preventing complications.

The primary product types in diabetes care include glucose monitoring devices, insulin pumps, and other related products. Glucose monitoring devices are medical tools designed to measure and track blood glucose levels, primarily for individuals with diabetes. The different types of diabetes include type 1 diabetes, type 2 diabetes, and other forms, with these products being used by various end users, including hospitals and clinics, home care settings, ambulatory care centers, and others.

The diabetes care market research report is one of a series of new reports from The Business Research Company that provides diabetes care market statistics, including the diabetes care industry's global market size, regional shares, competitors with the diabetes care market share, detailed diabetes care market segments, market trends and opportunities, and any further data you may need to thrive in the diabetes care market. This diabetes care market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The diabetes care market size has grown strongly in recent years. It will grow from $26.79 billion in 2024 to $29.25 billion in 2025 at a compound annual growth rate (CAGR) of 9.2%. The growth during the historic period can be attributed to rising obesity rates, increased demand for continuous monitoring devices, growing investment in diabetes research and development, and a rising demand for personalized diabetes care.

The diabetes care market size is expected to see strong growth in the next few years. It will grow to $41.21 billion in 2029 at a compound annual growth rate (CAGR) of 8.9%. Growth during the forecast period is expected to be driven by the increasing prevalence of diabetes, an expanding geriatric population, heightened awareness of diabetes management, and improved healthcare access in developing regions. Key trends anticipated in the forecast period include technological advancements in diabetes monitoring, the integration of artificial intelligence (AI) in diabetes care, improvements in insulin delivery systems, and the development of smart insulin devices.

The rising prevalence of obesity is anticipated to drive the expansion of the diabetes care market in the coming years. Obesity rates refer to the proportion of individuals within a population who have a body mass index (BMI) of 30 or above, indicating obesity. The growth in obesity is largely due to increased dependence on sedentary lifestyles and the widespread consumption of highly processed, calorie-dense foods that offer minimal nutritional value, leading to an imbalance between caloric intake and physical activity. Diabetes care is essential in addressing obesity-related health challenges by promoting better lifestyle habits, enhancing glucose regulation, and supporting weight management through advanced treatment options like insulin therapy and continuous glucose monitoring (CGM) technologies. For instance, in March 2024, the World Health Organization, an intergovernmental body based in Switzerland, reported that in 2022, 390 million adults were underweight, while 2.5 billion were overweight, including 890 million classified as obese. As a result, increasing obesity levels are fueling demand within the diabetes care market.

Leading companies in the diabetes care industry are innovating with new technologies, such as automated insulin delivery (AID) systems, to enhance glucose control by seamlessly integrating continuous glucose monitoring devices with insulin pumps for real-time insulin adjustments. AID systems combine CGMs with insulin pumps to automatically manage insulin levels based on current glucose readings, helping patients maintain more consistent blood sugar control. For example, in February 2024, Tandem Diabetes Care Inc., a U.S.-based medical device company focused on diabetes treatment, launched the Tandem Mobi-an ultra-compact, durable automated insulin delivery system. This discreet, tubed insulin pump can be fully operated via a smartphone app, eliminating the need for a traditional controller. The device is waterproof, rechargeable, and integrates with Dexcom's CGM system, utilizing Tandem's established Control-IQ technology to automate insulin dosing.

In January 2023, Tandem Diabetes Care Inc. acquired AMF Medical SA for an undisclosed amount. This acquisition is aimed at accelerating the development and commercialization of advanced patch pump technology, broadening Tandem's diabetes care offerings, and reaching a wider patient base. AMF Medical SA is a Switzerland-based company specializing in innovative insulin delivery solutions for diabetes management.

Major players in the diabetes care market are F. Hoffmann-La Roche Ltd., Sanofi S.A., Abbott Laboratories, Medtronic plc, Eli Lilly and Company, Novo Nordisk A/S, Boehringer Ingelheim Pharmaceuticals Inc., Terumo Corporation, Dexcom Inc., Dr. Reddy's Laboratories Limited, SD Biosensor Inc., Insulet Corporation, Tandem Diabetes Care Inc., LifeScan Inc., Ypsomed AG, Ascensia Diabetes Care Holdings AG, B. Braun Melsungen AG, Bionime Corporation, Arkray Inc., ACON Laboratories Inc., ViCentra B.V., Microtech Medical Ltd., Sinocare Inc., MicroGene Diagnostic Systems Pvt. Ltd.

North America was the largest region in the diabetes care market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in diabetes care report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the diabetes care market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The diabetes care market consists of revenues earned by entities by providing services such as insulin therapy and medication management, nutrition and diet planning, lifestyle modification support, and telemedicine and remote monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. The diabetes care market also consists of sales of products including dietary and nutritional products, medication delivery devices, and digital and software solutions. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Diabetes Care Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on diabetes care market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for diabetes care ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The diabetes care market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Subsegments

Table of Contents

1. Executive Summary

2. Diabetes Care Market Characteristics

3. Diabetes Care Market Trends And Strategies

4. Diabetes Care Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Diabetes Care Growth Analysis And Strategic Analysis Framework

6. Diabetes Care Market Segmentation

7. Diabetes Care Market Regional And Country Analysis

8. Asia-Pacific Diabetes Care Market

9. China Diabetes Care Market

10. India Diabetes Care Market

11. Japan Diabetes Care Market

12. Australia Diabetes Care Market

13. Indonesia Diabetes Care Market

14. South Korea Diabetes Care Market

15. Western Europe Diabetes Care Market

16. UK Diabetes Care Market

17. Germany Diabetes Care Market

18. France Diabetes Care Market

19. Italy Diabetes Care Market

20. Spain Diabetes Care Market

21. Eastern Europe Diabetes Care Market

22. Russia Diabetes Care Market

23. North America Diabetes Care Market

24. USA Diabetes Care Market

25. Canada Diabetes Care Market

26. South America Diabetes Care Market

27. Brazil Diabetes Care Market

28. Middle East Diabetes Care Market

29. Africa Diabetes Care Market

30. Diabetes Care Market Competitive Landscape And Company Profiles

31. Diabetes Care Market Other Major And Innovative Companies

32. Global Diabetes Care Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Diabetes Care Market

34. Recent Developments In The Diabetes Care Market

35. Diabetes Care Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기